AAAAAA

   
Results: 1-8 |
Results: 8
Relation between CD4 cell counts and HIV RNA levels at onset of opportunistic infections
Authors: Brambilla, AM Castagna, A Nocita, B Hasson, H Boeri, E Veglia, F Lazzarin, A
Citation: Am. Brambilla et al., Relation between CD4 cell counts and HIV RNA levels at onset of opportunistic infections, J ACQ IMM D, 27(1), 2001, pp. 44-48
Effect of genotypic resistance on the virological response to highly active antiretroviral therapy in cerebrospinal fluid
Authors: Cinque, P Presi, S Bestetti, A Pierotti, C Racca, S Boeri, E Morelli, P Carrera, P Ferrari, M Lazzarin, A
Citation: P. Cinque et al., Effect of genotypic resistance on the virological response to highly active antiretroviral therapy in cerebrospinal fluid, AIDS RES H, 17(5), 2001, pp. 377-383
Comparison of protease genotype and phenotype in HIV-1 infected patients exposed to more than one protease inhibitor
Authors: Gianotti, N Tambussi, G Boeri, E Lazzarin, A
Citation: N. Gianotti et al., Comparison of protease genotype and phenotype in HIV-1 infected patients exposed to more than one protease inhibitor, J BIOL REG, 15(2), 2001, pp. 166-169
Anti-cell antibodies in exposed seronegative individuals with HIV type 1-neutralizing activity
Authors: Lopalco, L Pastori, C Cosma, A Burastero, SE Capiluppi, B Boeri, E Beretta, A Lazzarin, A Siccardi, AG
Citation: L. Lopalco et al., Anti-cell antibodies in exposed seronegative individuals with HIV type 1-neutralizing activity, AIDS RES H, 16(2), 2000, pp. 109-115
Hepatitis B surface antigen clearance and appearance of antibodies againsthepatitis B surface antigen after treatment with recombinant interleukin 2in a human immunodeficiency virus-infected patient
Authors: Gianotti, N Uberti-Foppa, C Boeri, E Marinelli, M Tambussi, G Finazzi, R Lazzarin, A
Citation: N. Gianotti et al., Hepatitis B surface antigen clearance and appearance of antibodies againsthepatitis B surface antigen after treatment with recombinant interleukin 2in a human immunodeficiency virus-infected patient, HEPATOLOGY, 32(6), 2000, pp. 1409-1410
Recombinant interleukin-2 for treatment of HIV reduces hepatitis C viral load in coinfected patients
Authors: Uberti-Foppa, C De Bona, A Morsica, G Guffanti, M Gianotti, N Boeri, E Lazzarin, A
Citation: C. Uberti-foppa et al., Recombinant interleukin-2 for treatment of HIV reduces hepatitis C viral load in coinfected patients, AIDS, 13(1), 1999, pp. 140-141
SMART - study on mutations and antiretroviral therapy: preliminary results
Authors: Gianotti, N Moretti, F Tambussi, G Nozza, S Ciuffreda, D Lazzarin, A Racca, S Boeri, E Crucianelli, R Ferrari, M Moroni, M Angarano, G Sinicco, A
Citation: N. Gianotti et al., SMART - study on mutations and antiretroviral therapy: preliminary results, SEVENTH EUROPEAN CONFERENCE ON CLINICAL ASPECTS AND TREATMENT OF HIV-INFECTION, 1999, pp. 87-91
The HTLV European Research Network (HERN) Steering Committee
Authors: Weber, J Taylor, G Chieco-Bianchi, L de The, G Weiss, R Goubau, P Ebbesen, P Gessain, A Ozden, S Brahic, M Dokhelar, MC Guillemain, B von der Helm, K Bertazzoni, U Liso, V Varnier, O Saracco, A Huisman, JG Bangham, CRM Catovsky, D Matutes, E Dalgleish, A Lever, AML Mortimer, P Tosswill, J Noone, A Schulz, T Vandamme, AM Carton, H Willems, L Kirkhofs, P Wantzin, P Christiansen, CB Hall, W Mamoun, R Coste, J Hermine, O Gout, O Dodon, MD Wattel, E Desgranges, C Giraudon, P Pauli, G Niewiesk, S Kucherer, C Khazaie, K Grassmann, R Hatzakis, A Casoli, C Wicks, R Manca, F Galli, M Ferrante, P Boeri, E Lillo, F Macchi, B Avillez, F Caetano, M Soriano, V Illa, I Horal, P Andersson, S Krook, A Daenke, S Breuer, J Kelsey, S Nightingale, S Pagliuca, T Bain, B Brighty, D Rudge, P Ades, T Cann, AJ
Citation: J. Weber et al., The HTLV European Research Network (HERN) Steering Committee, BIOM HLTH R, 24, 1998, pp. 266-271
Risultati: 1-8 |